335 related articles for article (PubMed ID: 19718627)
1. Liver transplantation outcomes among Caucasians, Asian Americans, and African Americans with hepatitis B.
Bzowej N; Han S; Degertekin B; Keeffe EB; Emre S; Brown R; Reddy R; Lok AS;
Liver Transpl; 2009 Sep; 15(9):1010-20. PubMed ID: 19718627
[TBL] [Abstract][Full Text] [Related]
2. Racial disparities in liver transplantation for hepatitis B: to be or not to be.
Howell CD
Liver Transpl; 2009 Sep; 15(9):1007-9. PubMed ID: 19718630
[No Abstract] [Full Text] [Related]
3. Prognosis in liver transplantation recipients after hepatitis B virus recurrence.
Sun LY; Zhu ZJ; Qu W; Sun XY; Rao W; Liu Y
Hepatogastroenterology; 2014 Oct; 61(135):2047-51. PubMed ID: 25713909
[TBL] [Abstract][Full Text] [Related]
4. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
[TBL] [Abstract][Full Text] [Related]
5. High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation.
Lee EC; Kim SH; Lee SD; Park H; Lee SA; Park SJ
World J Gastroenterol; 2016 Apr; 22(14):3803-12. PubMed ID: 27076765
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation.
Faria LC; Gigou M; Roque-Afonso AM; Sebagh M; Roche B; Fallot G; Ferrari TC; Guettier C; Dussaix E; Castaing D; Brechot C; Samuel D
Gastroenterology; 2008 Jun; 134(7):1890-9; quiz 2155. PubMed ID: 18424269
[TBL] [Abstract][Full Text] [Related]
7. Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinoma.
Wong SN; Reddy KR; Keeffe EB; Han SH; Gaglio PJ; Perrillo RP; Tran TT; Pruett TL; Lok AS
Liver Transpl; 2007 Mar; 13(3):334-42. PubMed ID: 17154401
[TBL] [Abstract][Full Text] [Related]
8. Impact of the hepatitis B virus genotype on pre- and post-liver transplantation outcomes.
Gaglio P; Singh S; Degertekin B; Ishitani M; Hussain M; Perrillo R; Lok AS;
Liver Transpl; 2008 Oct; 14(10):1420-7. PubMed ID: 18825703
[TBL] [Abstract][Full Text] [Related]
9. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.
Chung GE; Kim W; Lee JH; Kim YJ; Yoon JH; Lee JM; Lee JY; Kim SH; Kim D; Lee HS
J Gastroenterol Hepatol; 2011 Nov; 26(11):1638-45. PubMed ID: 22011297
[TBL] [Abstract][Full Text] [Related]
10. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
[TBL] [Abstract][Full Text] [Related]
11. Recurrence of hepatitis C virus (genotype 4) infection after living-donor liver transplant in Egyptian patients.
Yosry A; Abdel-Rahman M; Esmat G; El-Serafy M; Omar A; Doss W; Zayed N; Said M; Ismail T; Hosny A; Marawan E; El-Malt O; Kamel RR; Hatata Y; El-Taweel A; Ghali A; Sabri H; Kamel S; El-Gabaly H
Exp Clin Transplant; 2009 Sep; 7(3):157-63. PubMed ID: 19715525
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of hepatitis B and C viral markers: clinical significance in Asian and Caucasian patients with hepatocellular carcinoma in the United States of America.
Hwang SJ; Tong MJ; Lai PP; Ko ES; Co RL; Chien D; Kuo G
J Gastroenterol Hepatol; 1996 Oct; 11(10):949-54. PubMed ID: 8912133
[TBL] [Abstract][Full Text] [Related]
13. HBV recurrence lowered by lamivudine/HBIG combination therapy in liver transplant patients: ten-year experience.
Yuan CH; Xiu DR; Jiang B; Li ZF; Li L; Song SB; Zhang TL
Hepatobiliary Pancreat Dis Int; 2013 Apr; 12(2):149-53. PubMed ID: 23558068
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes of liver transplantation for HBV-related hepatocellular carcinoma: data from the NIH HBV OLT study.
Han SH; Reddy KR; Keeffe EB; Soldevila-Pico C; Gish R; Chung RT; Degertekin B; Lok A;
Clin Transplant; 2011; 25(2):E152-62. PubMed ID: 21077950
[TBL] [Abstract][Full Text] [Related]
15. Combination of lamivudine and adefovir without hepatitis B immune globulin is safe and effective prophylaxis against hepatitis B virus recurrence in hepatitis B surface antigen-positive liver transplant candidates.
Gane EJ; Patterson S; Strasser SI; McCaughan GW; Angus PW
Liver Transpl; 2013 Mar; 19(3):268-74. PubMed ID: 23447403
[TBL] [Abstract][Full Text] [Related]
16. Prophylaxis against hepatitis B virus recurrence after liver transplantation: a registry study.
Shen S; Jiang L; Xiao GQ; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Xu MQ; Wei YG
World J Gastroenterol; 2015 Jan; 21(2):584-92. PubMed ID: 25593480
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B prophylaxis using lamivudine and individualized low-dose hepatitis B immunoglobulin in living donor liver transplantation.
Jiang L; Yan L; Wen T; Li B; Zhao J; Yang J; Xu M; Wang W
Transplant Proc; 2013; 45(6):2326-30. PubMed ID: 23953544
[TBL] [Abstract][Full Text] [Related]
18. Comparison of surgical outcomes for small hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a Chinese experience.
Li Q; Li H; Qin Y; Wang PP; Hao X
J Gastroenterol Hepatol; 2007 Nov; 22(11):1936-41. PubMed ID: 17914973
[TBL] [Abstract][Full Text] [Related]
19. Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation.
Fung J; Cheung C; Chan SC; Yuen MF; Chok KS; Sharr W; Dai WC; Chan AC; Cheung TT; Tsang S; Lam B; Lai CL; Lo CM
Gastroenterology; 2011 Oct; 141(4):1212-9. PubMed ID: 21762659
[TBL] [Abstract][Full Text] [Related]
20. Liver transplantation in patients with hepatitis B virus infection: outcome in Asian versus white patients.
Teo EK; Han SH; Terrault N; Luketic V; Jensen D; Keeffe EB; Lok AS;
Hepatology; 2001 Jul; 34(1):126-32. PubMed ID: 11431743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
